The ease of acquiring prior authorizations for a new formulary drug plays a part in evaluating oncology drugs that are new to the market.
Andrea Iannucci, PharmD, BCOP
Advertisement
Assistant Chief Pharmacist, UC Davis Health
Articles by Andrea Iannucci, PharmD, BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Extension Studies in TPIP Show Promise in PAH, PH-ILD
2
Bepirovirsen Approval Offers New Option for Chronic HBV Treatment
3
Inhaled Amikacin Raises Culture Conversion in New MAC Lung Disease
4
Bronchiectasis GWAS Highlights Candidate Targets Shared With COPD
5